Dr. Lacy Anderson explains sudden, short-term nausea and vomiting signal a stomach virus, while long-lasting bowel issues ...

Two research teams 3000 miles apart discover a common bacterium triggering chronic gastrointestinal pain — while developing a ...

Prokarium, a clinical-stage biopharmaceutical company pioneering the field of microbial immunotherapy, today announced the appointment of Ibs Mahmood as Chief Executive Officer (CEO). Ibs succeeds ...

The same antihistamines that put the brakes on allergy and cold symptoms may also ease stomach pain and other IBS symptoms.

The Mediterranean diet showed noninferiority and superiority in treating IBS vs. traditional dietary advice.The mechanism behind the findings remains unclear.

Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) are often confused but are distinct conditions. IBS is a functional disorder causing discomfort without lasting damage, while IBD ...

If you’re having symptoms of IBS, it’s important to see your doctor to get evaluated. Your doctor will likely give you a ...

The FDA has updated the label indication for linaclotide capsules for the treatment of irritable bowel syndrome with ...

The Food and Drug Administration (FDA) has approved Linzess ® (linaclotide) for the treatment of irritable bowel syndrome with constipation (IBS-C) in patients 7 years of age and older. Previously, ...

The FDA expands use of linaclotide to children as young as age 7 years with irritable bowel syndrome with constipation (IBS-C ...

FDA approves IBS drug for children, Linzess, to treat pediatric IBS-C in patients ages 7 and older with proven safety and efficacy.

Initially approved in 2012, linaclotide is already indicated for treating chronic idiopathic constipation and IBS-C in adults ...